Recurrent Small Cell Lung Cancer (SCLC) Completed Phase 2 Trials for 7-Hydroxystaurosporine (DB01933)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Small Cell Lung Cancer Recurrent / Refractory Small cell lung cancer / Recurrent Small Cell Lung Cancer / Recurrent Lung Small Cell Carcinoma / Recurrent Small Cell Lung Carcinoma

IndicationStatusPhase
DBCOND0122754 (Recurrent Small Cell Lung Cancer (SCLC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000989567-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung CancerTreatment